Loomis, Sayles & Company’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11
Closed -$3K 914
2023
Q2
$3K Sell
11
-9
-45% -$2.68K ﹤0.01% 905
2023
Q1
$6K Buy
+20
New +$5.53K ﹤0.01% 895
2022
Q3
Sell
-44
Closed -$9K 956
2022
Q2
$9K Hold
44
﹤0.01% 671
2022
Q1
$9K Buy
44
+14
+47% +$3.04K ﹤0.01% 726
2021
Q4
$7K Hold
30
﹤0.01% 755
2021
Q3
$8K Sell
30
-44
-59% -$14.4K ﹤0.01% 861
2021
Q2
$26K Buy
74
+34
+85% +$10.3K ﹤0.01% 643
2021
Q1
$11K Buy
+40
New +$10.8K ﹤0.01% 746
2019
Q1
Sell
-4,701
Closed -$1.42M 777
2018
Q4
$1.42M Sell
4,701
-4,602
-49% -$1.47M ﹤0.01% 527
2018
Q3
$3.29M Sell
9,303
-21,109
-69% -$7.27M 0.01% 508
2018
Q2
$8.83M Sell
30,412
-19,168
-39% -$5.39M 0.02% 450
2018
Q1
$13.6M Sell
49,580
-644
-1% -$200K 0.03% 348
2017
Q4
$16M Sell
50,224
-7,350
-13% -$2.36M 0.03% 331
2017
Q3
$18M Sell
57,574
-3,934
-6% -$1.16M 0.04% 306
2017
Q2
$16.7M Buy
61,508
+7,171
+13% +$1.9M 0.04% 302
2017
Q1
$14.9M Buy
54,337
+13,509
+33% +$3.82M 0.04% 330
2016
Q4
$11.6M Sell
40,828
-12,576
-24% -$3.73M 0.03% 402
2016
Q3
$16.7M Sell
53,404
-39,853
-43% -$11.8M 0.04% 314
2016
Q2
$22.6M Sell
93,257
-9,234
-9% -$2.43M 0.06% 238
2016
Q1
$26.7M Sell
102,491
-10,660
-9% -$2.82M 0.08% 193
2015
Q4
$34.7M Sell
113,151
-3,793
-3% -$1.09M 0.1% 146
2015
Q3
$34.1M Buy
116,944
+14,307
+14% +$4.72M 0.1% 158
2015
Q2
$41.5M Buy
102,637
+43,290
+73% +$17.4M 0.11% 155
2015
Q1
$25.1M Sell
59,347
-7,535
-11% -$2.97M 0.07% 262
2014
Q4
$22.7M Sell
66,882
-22,486
-25% -$7.27M 0.06% 285
2014
Q3
$29.6M Buy
89,368
+11,414
+15% +$3.76M 0.09% 205
2014
Q2
$24.6M Sell
77,954
-17,096
-18% -$5.15M 0.07% 277
2014
Q1
$29.1M Buy
95,050
+3,415
+4% +$1.08M 0.08% 230
2013
Q4
$25.6M Buy
91,635
+2,528
+3% +$654K 0.08% 254
2013
Q3
$21.5M Buy
89,107
+742
+0.8% +$166K 0.07% 299
2013
Q2
$19K Buy
+88,365
New +$18.9M 0.07% 318

Other funds holding BIIB